Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Net Income towards Common Stockholders (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Net Income towards Common Stockholders for 15 consecutive years, with $4.1 million as the latest value for Q4 2025.

  • Quarterly Net Income towards Common Stockholders fell 42.44% to $4.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.4 million through Dec 2025, up 103.3% year-over-year, with the annual reading at $17.4 million for FY2025, 103.3% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was $4.1 million at Niagen Bioscience, down from $4.6 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $7.2 million in Q4 2024, with the low at -$8.9 million in Q3 2021.
  • Average Net Income towards Common Stockholders over 5 years is -$1.2 million, with a median of -$1.2 million recorded in 2022.
  • The sharpest move saw Net Income towards Common Stockholders tumbled 110.11% in 2021, then soared 24160.0% in 2025.
  • Over 5 years, Net Income towards Common Stockholders stood at -$5.3 million in 2021, then skyrocketed by 72.88% to -$1.4 million in 2022, then skyrocketed by 107.89% to $114000.0 in 2023, then skyrocketed by 6197.37% to $7.2 million in 2024, then plummeted by 42.44% to $4.1 million in 2025.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at $4.1 million, $4.6 million, and $3.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.